Statistical Properties of the Keyboard Design with Extension to Drug-Combination Trials
Haitao Pan, Ruitao Lin, and Ying Yuan

TL;DR
This paper analyzes the theoretical properties of the keyboard design for phase I trials, extends it to drug-combination trials, and validates its performance through extensive simulations and an R Shiny application.
Contribution
It provides the first theoretical analysis of the keyboard design, extends it to drug combinations, and offers practical tools for implementation.
Findings
Theoretical properties such as optimality, coherence, and convergence are established.
The extended design performs well in complex dose-toxicity scenarios.
An R Shiny app facilitates practical implementation of the design.
Abstract
The keyboard design is a novel phase I dose-finding method that is simple and has good operating characteristics. This paper studies theoretical properties of the keyboard design, including the optimality of its decision rules, coherence in dose transition, and convergence to the target dose. Establishing these theoretical properties explains the mechanism of the design and provides assurance to practitioners regarding the behavior of the keyboard design. We further extend the keyboard design to dual-agent dose-finding trials, which inherit the same statistical properties and simplicity as the single-agent keyboard design. Extensive simulations are conducted to evaluate the performance of the proposed keyboard drug-combination design using a novel, random two-dimensional dose--toxicity scenario generating algorithm. The simulation results confirm the desirable and competitive operating…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Optimal Experimental Design Methods · Computational Drug Discovery Methods
